In re Zofran (Ondansetron) Products Liability Litigation
In re Zofran (Ondansetron) Products Liability Litigation
Opinion of the Court
I. Background
This case is one of many consolidated in a multi-district litigation proceeding arising out of claims that the use of the drug Zofran (ondansetron) by pregnant .women caused birth defects. Plaintiffs Kierra Simmons, Tia Hancock, Joanna Tyler, and Dawn Barchiesi originally filed suit in Missouri state .court against defendant GlaxoSmithKline, LLC (“GSK”) alleging that their use of Zofran- during pregnancy caused congenital heart defects in .their children. Only one of the original four plaintiffs—Kierra Simmons—is a Missouri citizen. According to the complaint, Tia Hancock is a citizen of Delaware; Joanna Tyler is a citizen.of North Carolina; and Dawn Barchiesi is a citizen of Pennsylvania.
GSK removed the action .'to the United States District Court for the Eastern District' of Missouri and moved 'to dismiss the claims of the three non-Missouri plaintiffs
After the action was transferred to this Court, plaintiffs renewed their motion to remand for lack of subject-matter jurisdiction. GSK opposed, contending that the three non-Missouri plaintiffs should be dismissed for lack of personal jurisdiction.
Plaintiffs have moved to certify the Court’s order for interlocutory appeal pursuant to 28 U.S.C. § 1292(b). For the reasons stated below, that motion will be denied.
II. Legal Standard
Under 28 U.S.C. § 1292(b), otherwise unappealable district court orders may be certified for interlocutory appeal, subject to the court’s discretion, if (1) the order sought" to be appealed “inyolves a controlling question of law”; (2) “there is substantial ground for difference of opinion” regarding that question of law; and (3) “an immediate appeal from the order may materially advance the ultimate termination of the litigation.” 28 U.S.C. § 1292(b). Interlocutory certification under § 1292(b) “should be used sparingly and only in exceptional circumstances.” McGillicuddy v. Clements, 746 F.2d 76, 76 n.1 (1st Cir. 1984).
III. Discussion
An interlocutory appeal requires “exceptional circumstances,”, .but none are present here. Even assuming that the Court’s May 4, 2016 order involved a controlling question of law, there is not a “substantial ground” for difference of opinion regarding that question. A substantial ground for difference of opinion exists “about an issue when the matter involves ‘one or more difficult and pivotal questions of law not settled by controlling authority.’ ” Philip Morris Inc. v. Harshbarger, 957 F.Supp. 327, 330 (D. Mass. 1997) (quoting McGillicuddy, 746 F.2d at 76 n.1). Plaintiffs contend that there ' is • such a ground for difference of opinion concerning the order in which courts should decide questions of personal jurisdiction and subject-matter" jurisdiction. But that question has been settled by controlling authority. In Ruhrgas, the Supreme Court “held that there is no mandatory ‘sequencing of jurisdictional issues.’” Sinochem Int’l Co. v. Malaysia Int’l Shipping Corp., 549 U.S. 422, 431, 127 S.Ct. 1184, 167 L.Ed.2d 15 (2007) (quoting Ruhrgas, 526 U.S. at 584, 119 S.Ct. 1563). Courts therefore have the discretion to decide issues of personal jurisdiction before deciding whether the court has subject-matter jurisdiction,‘particularly when the question of personal jurisdiction is a straightforward. Ruhrgas, 526 U.S. at 587-88, 119 S.Ct. 1563.
Furthermore, it is far from clear that interlocutory appeal will advance the ultimate termination of this litigation. Plaintiffs contend that if the Court’s May 4, 2016 order is reversed and subject-matter jurisdiction is addressed first, the case will be remanded to state court, thus disposing of the federal litigation. However, as defendant points out, it opposed remand not only on the ground of lack of personal jurisdiction, but also on the grounds that the doctrines of fraudulent joinder and procedural misjoinder preclude a finding that the parties are not diverse. At this time, and without having addressed the merits of defendant’s second argument, the contention that appeal will likely result in remand is conjectural. See Johnson v. Watts Regulator Co., 1994 WL 421112 at *2 (D.N.H. 1994) (denying interlocutory appeal where, among other things, “defendant’s claim that an interlocutory appeal would advance the ultimate termination of the litigation is conjecture.”).
IV. Conclusion
For the foregoing reasons, plaintiffs’ motion to certify the Court’s order for interlocutory appeal (Docket No. 59) is DENIED.
So Ordered.
. GSK also opposed remand on the grounds that, even- if the Court considered subject-matter jurisdiction first, the doctrines of fraudulent joinder and procedural misjoinder precluded a finding that the parties were not diverse.
Reference
- Full Case Name
- IN RE: ZOFRAN (ONDANSETRON) PRODUCTS LIABILITY LITIGATION. This Document Relates to: Kierra Simmons v. Glaxosmithkline LLC, 1:15-cv-13760-fds
- Cited By
- 5 cases
- Status
- Published